WPI 3331 (Bupropion Extended-Release (XL) 150 mg)
Pill imprint WPI 3331 has been identified as Bupropion hydrochloride extended-release (XL) 150 mg.
Bupropion is used in the treatment of depression; smoking cessation; anxiety; adhd; sexual dysfunction, ssri induced (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 3331 (Bupropion Extended-Release (XL) 150 mg)
- 150 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Miscellaneous antidepressants
Smoking cessation agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
methacrylic acid - ethyl acrylate copolymer (1:1) type a
|NDC Code||Manufacturer / Repackager|
|54868-5927||Physicians Total Care Inc (repackager)|
|21695-0279||Rebel Distributors Corp (repackager)|
|33261-0449||Aidarex Pharmacuticals LLC (repackager)|
|33261-0680||Aidarex Pharmacuticals LLC (repackager)|
Note: Inactive ingredients may vary.
Bupropion hydrochloride extended-release (XL) is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...